1374342-27-4

Upstream product

• 352437-09-3 tert-butyl 4-(4-bromophenyl)piperazine-1-carboxylate 
• 66698-28-0 1-(4-bromophenyl)piperazine 
• 6226-25-1 2,2,2-trifluoroethyl trifluoromethanesulphonate 

Downstream Products

• 1374339-44-2 1-(6-{4-(difluoromethyl)-4'-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]biphenyl-2-yl}pyridin-2-yl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylic acid 
• 1374342-28-5 1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4-(2,2,2-trifluoroethyl)piperazine 

Relevant academic research and scientific papers

PYRROLO-AROMATIC HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF

The present invention relates to pyrrolo-aromatic heterocyclic compounds, a preparation method therefor and medical use thereof. Particularly, the present invention relates to a compound represented by formula I, a preparation method therefor, a pharmaceu

SOLUBLE GUANYLATE CYCLASE ACTIVATORS

This inventions relates to compounds having the structure Formula I and pharmaceutically acceptable salts thereof which are soluble guanylate cyclase activators. The compounds are useful for treatment or prevention of cardiovascular diseases, endothelial dysfunction, diastolic dysfunction, atherosclerosis, hypertension, pulmonary hypertension, angina pectoris, thromboses, restenosis, myocardial infarction, strokes, cardiac insufficiency, pulmonary hypertonia, erectile dysfunction, asthma bronchiale, chronic kidney insufficiency, diabetes, or cirrhosis of the liver.